Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Direct health-care cost of head and neck cancers: a population-based study in north-eastern Italy.

Polesel J, Lupato V, Collarile P, Vaccher E, Fanetti G, Giacomarra V, Palazzari E, Furlan C, Matrone F, Navarria F, Gobitti C, Minatel E, Serraino D, Birri S, Franchin G.

Med Oncol. 2019 Feb 28;36(4):31. doi: 10.1007/s12032-019-1256-2.

PMID:
30815763
2.

Voxel-by-voxel correlation between radiologically radiation induced lung injury and dose after image-guided, intensity modulated radiotherapy for lung tumors.

Avanzo M, Barbiero S, Trovo M, Bissonnette JP, Jena R, Stancanello J, Pirrone G, Matrone F, Minatel E, Cappelletto C, Furlan C, Jaffray DA, Sartor G.

Phys Med. 2017 Oct;42:150-156. doi: 10.1016/j.ejmp.2017.09.127. Epub 2017 Sep 23.

PMID:
29173909
3.

The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy.

Polesel J, Furlan C, Birri S, Giacomarra V, Vaccher E, Grando G, Gobitti C, Navarria F, Schioppa O, Minatel E, Bidoli E, Barzan L, Franchin G.

Oral Oncol. 2017 Apr;67:175-182. doi: 10.1016/j.oraloncology.2017.02.009. Epub 2017 Mar 3.

PMID:
28351574
4.

Cell-free DNA as a prognostic marker in stage I non-small-cell lung cancer patients undergoing stereotactic body radiotherapy.

Bortolin MT, Tedeschi R, Bidoli E, Furlan C, Basaglia G, Minatel E, Gobitti C, Franchin G, Trovò M, De Paoli P.

Biomarkers. 2015;20(6-7):422-8. doi: 10.3109/1354750X.2015.1094139. Epub 2015 Nov 2.

PMID:
26526078
5.

Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.

Minatel E, Trovo M, Bearz A, Di Maso M, Baresic T, Drigo A, Barresi L, Furlan C, Del Conte A, Bruschi G, Fontana P, Pagan V, Franchin G.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):606-13. doi: 10.1016/j.ijrobp.2015.06.029. Epub 2015 Jun 20.

PMID:
26281826
6.

Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer.

Trovo M, Minatel E, Durofil E, Polesel J, Avanzo M, Baresic T, Bearz A, Del Conte A, Franchin G, Gobitti C, Rumeileh IA, Trovo MG.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1114-9. doi: 10.1016/j.ijrobp.2014.01.012.

PMID:
24661664
7.

Complete metabolic remission with Gefitinib in a hemodialysis patient with bone metastases from non-small cell lung cancer.

Del Conte A, Minatel E, Schinella D, Baresic T, Basso SM, Lumachi F.

Anticancer Res. 2014 Jan;34(1):319-22.

PMID:
24403481
8.

Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.

Minatel E, Trovo M, Polesel J, Baresic T, Bearz A, Franchin G, Gobitti C, Rumeileh IA, Drigo A, Fontana P, Pagan V, Trovo MG.

Lung Cancer. 2014 Jan;83(1):78-82. doi: 10.1016/j.lungcan.2013.10.013. Epub 2013 Oct 27.

PMID:
24216141
9.

Concurrent chemoradiotherapy with tomotherapy in locally advanced Non-Small Cell Lung Cancer: a phase I, docetaxel dose-escalation study, with hypofractionated radiation regimen.

Bearz A, Minatel E, Rumeileh IA, Borsatti E, Talamini R, Franchin G, Gobitti C, Del Conte A, Trovò M, Baresic T.

BMC Cancer. 2013 Oct 31;13:513. doi: 10.1186/1471-2407-13-513.

10.

Tomotherapy after pleurectomy or decortication or biopsy for malignant pleural mesothelioma.

Trovo M, Minatel E.

J Thorac Oncol. 2013 May;8(5):e50-1. doi: 10.1097/JTO.0b013e31828c2730. No abstract available.

11.

Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung.

Minatel E, Trovo M, Polesel J, Rumeileh IA, Baresic T, Bearz A, Del Conte A, Franchin G, Gobitti C, Drigo A, Dassie A, Pagan V, Trovo MG.

J Thorac Oncol. 2012 Dec;7(12):1862-1866. doi: 10.1097/JTO.0b013e318272601f.

12.

Treatment of recurrent high-grade gliomas with GliaSite brachytherapy: a prospective mono-institutional Italian experience.

Gobitti C, Borsatti E, Arcicasa M, Roncadin M, Franchin G, Minatel E, Skrap M, Zanotti B, Tuniz F, Cimitan M, Capra E, Drigo A, Trovò MG.

Tumori. 2011 Sep-Oct;97(5):614-9. doi: 10.1700/989.10721.

PMID:
22158493
13.

Intensity-modulated radiotherapy (IMRT)/Tomotherapy following neoadjuvant chemotherapy in stage IIB-IVA/B undifferentiated nasopharyngeal carcinomas (UCNT): a mono-institutional experience.

Franchin G, Vaccher E, Talamini R, Politi D, Gobitti C, Minatel E, Lleshi A, Sartor G, Mascarin M, Rumeileh IA, Trovò MG, Barzan L.

Oral Oncol. 2011 Sep;47(9):905-9. doi: 10.1016/j.oraloncology.2011.06.503. Epub 2011 Jul 23.

PMID:
21783403
14.

Helical tomotherapy in children and adolescents: dosimetric comparisons, opportunities and issues.

Mascarin M, Giugliano FM, Coassin E, Drigo A, Chiovati P, Dassie A, Franchin G, Minatel E, Trovò MG.

Cancers (Basel). 2011 Oct 25;3(4):3972-90. doi: 10.3390/cancers3043972.

15.

Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma.

Franchin G, Minatel E, Politi D, Gobitti C, Talamini R, Vaccher E, Savignano MG, Trovo M, Sulfaro S, Barzan L.

Cancer. 2009 Jun 1;115(11):2464-71. doi: 10.1002/cncr.24252.

16.

Organ preservation in locally advanced head and neck cancer of the larynx using induction chemotherapy followed by improved radiation schemes.

Franchin G, Vaccher E, Politi D, Minatel E, Gobitti C, Talamini R, Spazzapan S, Savignano MG, Trovò MG, Barzan L.

Eur Arch Otorhinolaryngol. 2009 May;266(5):719-26. doi: 10.1007/s00405-008-0798-2. Epub 2008 Sep 9.

PMID:
18779973
17.

Thoracic radiation therapy and concomitant low-dose daily paclitaxel in non-small cell lung cancer: a phase I study.

Gobitti C, Franchin G, Minatel E, Gigante M, Basso B, Bujor L, Trovò MG.

Oncol Rep. 2005 Dec;14(6):1647-53.

PMID:
16273271
18.

Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma.

Franchin G, Vaccher E, Gobitti C, Minatel E, Politi D, Talamini R, Di Gennaro G, Savignano G, Trovò MG, Tirelli U, Barzan L.

Oral Oncol. 2005 May;41(5):526-33. Epub 2005 Apr 9.

PMID:
15878759
19.

Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.

Franchin G, Minatel E, Gobitti C, Talamini R, Vaccher E, Sartor G, Politi D, Trovò MG, Barzan L.

Cancer. 2003 Aug 15;98(4):765-72.

20.

Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial.

Olmi P, Crispino S, Fallai C, Torri V, Rossi F, Bolner A, Amichetti M, Signor M, Taino R, Squadrelli M, Colombo A, Ardizzoia A, Ponticelli P, Franchin G, Minatel E, Gobitti C, Atzeni G, Gava A, Flann M, Marsoni S.

Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):78-92.

PMID:
12504039

Supplemental Content

Loading ...
Support Center